These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28938409)

  • 21. A practical approach to the diagnosis of polycystic ovary syndrome.
    Chang RJ
    Am J Obstet Gynecol; 2004 Sep; 191(3):713-7. PubMed ID: 15467530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin resistance, hypersecretion of LH, and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome.
    Poretsky L; Piper B
    Obstet Gynecol; 1994 Oct; 84(4):613-21. PubMed ID: 8090402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ovarian theca cell. IV. The hyperthecosis syndrome.
    SHIPPEL S
    J Obstet Gynaecol Br Emp; 1955 Jun; 62(3):321-53. PubMed ID: 14392512
    [No Abstract]   [Full Text] [Related]  

  • 24. Virilizing nodular ovarian stromal hyperthecosis, diabetes mellitus and insulin resistance in a postmenopausal woman.
    Tuffnell DJ
    Br J Obstet Gynaecol; 1990 Jan; 97(1):89. PubMed ID: 2306435
    [No Abstract]   [Full Text] [Related]  

  • 25. Ovarian hyperandrogenism and androgen-producing tumors.
    Lobo RA
    Endocrinol Metab Clin North Am; 1991 Dec; 20(4):773-805. PubMed ID: 1778177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Insulin sensitizers in the treatment of polycystic ovary].
    Ortiz Núñez DA; Hernández Marín I; Ayala AR
    Ginecol Obstet Mex; 2005 Jun; 73(6):315-27. PubMed ID: 16309038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Commentary: Polycystic ovary syndrome--increased or preserved ovarian sensitivity to insulin?
    Poretsky L
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2859-60. PubMed ID: 16684824
    [No Abstract]   [Full Text] [Related]  

  • 28. [Insulin resistance in polycystic ovary syndrome].
    Aquino Carlos P; Hernández Valencia M
    Ginecol Obstet Mex; 1998 Nov; 66():446-51. PubMed ID: 9823701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Polycystic ovary syndrome: relationship of insulin tissular sensitivity, LH secretion and ovarian morphophysiologic changes].
    Sir-Petermann T; Alba F; Castillo T; Muñoz A; Cortínez A; Maliqueo M; Calvillán M
    Rev Med Chil; 1998 Sep; 126(9):1049-57. PubMed ID: 9922507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-Mediated Diseases: Adrenal Mass and Polycystic Ovary Syndrome.
    Muscogiuri G; Colao A; Orio F
    Trends Endocrinol Metab; 2015 Oct; 26(10):512-514. PubMed ID: 26412152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic resonance imaging appearance of ovarian stromal hyperplasia and ovarian hyperthecosis.
    Rosenkrantz AB; Popiolek D; Bennett GL; Hecht EM
    J Comput Assist Tomogr; 2009; 33(6):912-6. PubMed ID: 19940659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases.
    Zhang C; Sung CJ; Quddus MR; Simon RA; Jazaerly T; Lawrence WD
    Hum Pathol; 2017 Jan; 59():120-124. PubMed ID: 27746268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Polycystic ovary syndrome and insulin resistance].
    Puder J; Pralong F
    Rev Med Suisse; 2009 Apr; 5(198):779-82. PubMed ID: 19418980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
    Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
    Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Insulin resistance and polycystic ovary syndrome].
    Dewailly D; Cortet-Rudelli C; Nobels F; Henric B; Longelin C; Fossati P
    Ann Endocrinol (Paris); 1992; 53(1):1-7. PubMed ID: 1444176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current perspectives of insulin resistance and polycystic ovary syndrome.
    Pauli JM; Raja-Khan N; Wu X; Legro RS
    Diabet Med; 2011 Dec; 28(12):1445-54. PubMed ID: 21950959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin resistance and polycystic ovarian syndrome.
    Dewailly D; Cortet-Rudelli C
    Horm Res; 1992; 38(1-2):41-5. PubMed ID: 1306514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unusual ovarian changes (hyperthecosis) in pregnancy.
    LYNCH MJ; KYLE PR; RAPHAEL SS; BRUCE-LOCKHART P
    Am J Obstet Gynecol; 1959 Feb; 77(2):335-47. PubMed ID: 13617328
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular mechanisms of insulin resistance in polycystic ovary syndrome.
    Diamanti-Kandarakis E; Papavassiliou AG
    Trends Mol Med; 2006 Jul; 12(7):324-32. PubMed ID: 16769248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different phenotypes of polycystic ovary syndrome by Rotterdam criteria are differently steroidogenic but similarly insulin resistant.
    Wang Y; Qu J; Wu X; Hou L; Erkkola R; Wang Y
    Fertil Steril; 2010 Mar; 93(4):1362-5. PubMed ID: 19782351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.